Search results for " emerging biotech" in Articles / App Notes

Article Setting Standards for Biotech Therapeutics in India
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission. By: Anurag S. Rathore, PhD, Renu Jain, M. Kalaivani, Gunjan Narula, G. N. Singh BioPharm Inter…

Article Science Focus Fuels Successful Process Development for Startups
Converting challenges to opportunities While emerging biotechs face these numerous challenges, they also have some advantages over established pharma companies and can in some cases convert those …

Article Maximum Output Starts with Optimized Upstream Processing
That is at least true for large biopharmaceutical companies, but small and emerging biotech companies typically rely on the manufacturing capacity, expertise, and flexibility of CDMOs to bring their c…

Article Quality by design for biotechnology products—part 1
A PhRMA Working Group's advice on applying QbD to biotech. By Taruna Arora, Roger Greene, Jennifer Mercer, Paul Tsang, Meg Casais, Stuart Feldman, Jutta Look, Tony Lubiniecki, Joseph Mezzatesta,…

Article The Tide Stays High
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017. By Jim Miller A year ago, the outlook for contract services was a little uncertain. Equity markets’ appeti…

Article Biomanufacturing Outsourcing Globalization Continues
May 02, 2015 By Eric S. Langer BioPharm International Volume 28, Issue 5 Biopharmaceutical manufacturing clusters continue to emerge outside of the traditional hubs of North America …

Article Biopharma Seeks Balance
Biopharma Seeks Balance Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science. By Rita C. Peters …

Article Moving PAT from Concept to Reality
The learning curve for process analytical technology has slowed widespread adoption. By Cynthia A. Challener alexlmx a- Stock.Adobe.com Process analytical technology (P…

Article Modular Manufacturing Platforms for Biologics
May 01, 2015 By Randi Hernandez BioPharm International Volume 28, Issue 5 It should come as no surprise that the good design principles governing the execution of pharmaceutical manu…

Article Innovative Therapies Require Modern Manufacturing Systems
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients. By Jill Wechsler FDA set a 19-year record in 2015 in approving more new drugs and biologics, and …

Show All Results

Next Page